Sleepnet Corporation
The goal of this study is to evaluate the effectiveness of the Elara APAP device.
A prospective open label study to assess the efficacy of the Elara APAP device when used in patients with obstructive sleep apnea. Subjects will sign Informed Consent and undergo screening/baseline and a 1 night in-lab PSG.
Inclusion Criteria: 1. Body weight ≥ 30kg 2. Willing and able to consent, adhere to study requirements and receive mask treatment 3. ≥ 18 years of age 4. Diagnosed with OSA (Total AHI \>15 events/hr) by a practicing physician within the last 6 months. A re-diagnosis may be necessary to establish current baseline AHI in case there has been significant weight change or other co-morbidities since the previous diagnosis (per PI discretion) 5. Currently utilizing an APAP Device for ongoing treatment of OSA Exclusion Criteria: 1. Body weight \< 30kg 2. Female currently bearing a child or intendin…
Subject to have a 1 night in-lab PSG
Arctuva estimate
Verify or correct the compensation shown for this listing.